Zak Mir is joined by Sunday Roast regulars Albert Arthur, Kevin Hornsby and Phil Carroll for more stock market banter. The lads through their stocks of the moment, and speak
Zak Mir is joined by Sunday Roast regulars Albert Arthur, Kevin Hornsby and Phil Carroll for more stock market banter. The lads through their stocks of the moment, and speak
Zak Mir takes a technical analysis look at some of the most followed small caps on the London market. Today’s selection includes Arkle, Blencowe, Canadian Overseas, Contango, Hurricane, Itaconix, JKX
Zak Mir takes a technical view on some of the best looking charting setups amongst on the London small-cap market. Today’s selection includes Ebiquity, Fusion Antibodies, Galantas, Ipax, Mobile Tornado,
The stock market story featuring two like-minded investors Peter Pan @PanPeterS5 & Simon Huckle @sihuckle discuss their times on the market. Well done boys @JtZulu
Zak Mir is joined by regulars Albert Arthur, Kevin Hornsby and Phil Carroll for more stock market banter. This week’s guests are Kyler Hardy and Rory Kutluoglu from Cloudbreak Discovery
Synairgen announces results of in vitro studies showing antiviral activity of interferon-beta against key SARS-CoV-2 variants
Huge honour to support Ride4Rahma Challenging 70-mile ride from Dewsbury to the historic city of York to raise funds for ongoing projects in the Balkans registration charity, please donating here & share
Preliminary results for the year ended 31 December 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Grab a coffee, settle down and listen to the guy’s view – thoughts covering this week in the markets. New and exclusive to Share Talk.
People making exaggerated claims about a company or its prospects is something which we are all familiar with regarding the stock market. But of course, if “ramping” worked, every stock
Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial